

VCBeat Health Contact Us

China Healthcare Select

Vertical Industries 

Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory

Home Binhui Biopharm Submits IPO Application to HKEX, Pioneering HSV-2 Based Oncolytic Virus Therapies

Binhui Biopharm Submits IPO Application to HKEX, Pioneering HSV-2 Based Oncolytic Virus Therapies

CST Updated Apr 03, 2026 09:22

Share:

vcbeatglobal@vcbeat.net 

SERVICES

Partnership Development Market Entry Advisory Ecosystem Engagement Advisory

COMPANY

About VCBeat Why VCBeat Contact Us

CHANNELS

China Healthcare Select Insights MNC China Lens Events VB100 GMPC

MORE

PRIVACY VCBEAT CHINA

© 2025 VCBeat. All rights reserved.